Last week, Deputy Broughan wrote about access to Spinraza for SMA sufferers. Another treatment for a rare disease that he has consistently been raising has been access to Kuvan for people with PKU (Phenylketonuria).
Today, Deputy Broughan received the following welcome response from the HSE following his most recent Parliamentary Question on the matter: